XARACOLL is a Parenteral Implant in the Human Prescription Drug category. It is labeled and distributed by Innocoll Pharmaceuticals. The primary component is Bupivacaine.
| Product ID | 51715-100_23477215-fcfc-4b11-a5c3-b2034c31aefb |
| NDC | 51715-100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | XARACOLL |
| Generic Name | Bupivacaine Hcl Collagen-matrix |
| Dosage Form | Implant |
| Route of Administration | PARENTERAL |
| Marketing Start Date | 2020-08-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209511 |
| Labeler Name | INNOCOLL PHARMACEUTICALS |
| Substance Name | BUPIVACAINE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-08-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XARACOLL 90738266 not registered Live/Pending |
Innocoll Pharmaceuticals Limited 2021-05-27 |
![]() XARACOLL 88806837 not registered Live/Pending |
Innocoll Pharmaceuticals Limited 2020-02-22 |
![]() XARACOLL 87724683 not registered Live/Pending |
Innocoll Pharmaceuticals Limited 2017-12-18 |
![]() XARACOLL 85080255 4092973 Dead/Cancelled |
Innocoll Pharmaceuticals Limited 2010-07-08 |